Classic Malaria Publications

1. Alves FP, Durlacher RR, Menezes MJ, Krieger H, Silva LH, Camargo EP.
   High prevalence of asymptomatic Plasmodium vivax and Plasmodium falciparum infections in native Amazonian populations.
   Am J Trop Med Hyg. 2002 Jun;66(6):641-8.
   PMID: 12224567
2. Ariey F, Robert V.
   The puzzling links between malaria transmission and drug resistance.
   Trends Parasitol. 2003 Apr;19(4):158-60; author reply 160-1.
   PMID: 12689643
3. Basco L, Ringwald P.
   [Drug-resistant malaria: problems with its definition and technical approaches] in French
   Sante. 2000 Jan-Feb;10(1):47-50.
   PMID: 10827363
4. Bloland PB, Ettling M, Meek S.
   Combination therapy for malaria in Africa: hype or hope?
   Bull World Health Organ. 2000;78(12):1378-88. Epub 2003 Nov 17.
   PMID:11196485
5. Cortese JF, Caraballo A, Contreras CE, Plowe CV.< /br>Origin and dissemination of Plasmodium falciparum drug-resistance mutations in South America.
   J Infect Dis. 2002 Oct 1;186(7):999-1006. Epub 2002 Sep 9.
   PMID: 12232841
6. Cortese JF, Plowe CV.
   Antifolate resistance due to new and known Plasmodium falciparum dihydrofolate reductase mutations expressed in yeast.
   Mol Biochem Parasitol. 1998 Aug 1;94(2):205-14.
   PMID:9747971
7. Danis M, Bricaire F.
   The new drug combinations: their place in the treatment of uncomplicated Plasmodium falciparum malaria.
   Fundam Clin Pharmacol. 2003 Apr;17(2):155-60.
   PMID: 12667225
8. Djimdé A, Doumbo OK, Cortese JF, Kayentao K, Doumbo S, Diourte Y, Dicko A, Su XZ, Nomura T, Fidock DA, Wellems TE, Plowe CV, Coulibaly D.
   A molecular marker for chloroquine-resistant falciparum malaria.
   N Engl J Med, 344: 257-63.
   PMID: 11172152
9. Djimdé A, Doumbo OK, Steketee RW, Plowe CV.
   Application of a molecular marker for surveillance of chloroquine- resistant falciparum malaria.
   Lancet. 2001 Sep 15;358(9285):890-1.
   PMID: 11567708
10. Dorsey G, Kamya MR, Singh A, Rosenthal PJ.
    Polymorphisms in the Plasmodium falciparum pfcrt and pfmdr-1 genes and clinical response to chloroquine in Kampala, Uganda.
    J Infect Dis. 2001 May 1;183(9):1417-20. Epub 2001 Mar 27.
    PMID: 11294677
11. Duraisingh MT, Curtis J, Warhurst DC.
    Plasmodium falciparum: detection of polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes by PCR and restriction digestion.
    Exp Parasitol. 1998 May;89(1):1-8.
    PMID: 9603482
12. Durand R, Huart V, Jafari S, Le Bras J.
    Rapid Detection of a Molecular Marker for Chloroquine-Resistant Falciparum Malaria.
    Antimicrob Agents Chemother. 2002 Aug;46(8):2684-6.
    PMID: 12121957
13. Hastings I.
    Response to: The puzzling links between malaria transmission level and drug resistance.
    Trends Parasitol. 2003 Apr;19(4):158-60; author reply 160-1.
    PMID: 12689643
14. Hastings IM, D'Alessandro U.
    Modelling a Predictable Disaster:The Rise and Spread of Drug-resistant Malaria.
    Parasitol Today. 2000 Aug;16(8):340-7.
    PMID: 10900482
15. Hastings MD, Bates SJ, Blackstone EA, Monks SM, Mutabingwa TK, Sibley CH.
    Highly pyrimethamine-resistant alleles of dihydrofolate reductase in isolates of Plasmodium falciparum from Tanzania.
    Trans R Soc Trop Med Hyg. 2002 Nov-Dec;96(6):674-6.
    PMID: 12630380
16. Hastings MD, Sibley CH.
    Pyrimethamine and WR99210 exert opposing selection on dihydrofolate reductase from Plasmodium vivax.
    Proc Natl Acad Sci U S A. 2002 Oct 1;99(20):13137-41. Epub 2002 Aug 27.
    PMID: 12198181
17. Kublin JG, Dzinjalamala FK, Kamwendo DD, Malkin EM, Cortese JF, Martino LM, Mukadam RA, Rogerson SJ, Lescano AG, Molyneux ME, Winstanley PA, Chimpeni P, Taylor TE, Plowe CV.
    Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria.
    J Infect Dis. 2002 Feb 1;185(3):380-8. Epub 2002 Jan 17.
    PMID: 11807721
18. Le Bras J, Durand R.
    The mechanisms of resistance to antimalarial drugs in Plasmodium falciparum.
    Fundam Clin Pharmacol. 2003 Apr;17(2):147-53.
    PMID: 12667224
19. Mendez F, Munoz A, Carrasquilla G, Jurado D, Arevalo-Herrera M, Cortese JF, Plowe CV.
    Determinants of treatment response to sulfadoxine-pyrimethamine and subsequent transmission potential in falciparum malaria.
    Am J Epidemiol. 2002 Aug 1;156(3):230-8.
    PMID: 12142257
20. Mookherjee S, Howard V, Nzila-Mouanda A, Watkins W, Sibley CH.
    Identification and analysis of dihydrofolate reductase alleles from Plasmodium falciparum present at low frequency in polyclonal patient samples.
    Am J Trop Med Hyg. 1999 Jul;61(1):131-40.
    PMID: 10432070
21. Noedl H, Wongsrichanalai C, Wernsdorfer W.
    Malaria drug-sensitivity testing: new assays, new perspectives.
    Trends Parasitol. 2003 Apr;19(4):175-81.
    PMID: 12689648
22. Nosten F, Brasseur P.
    Combination therapy for malaria: the way forward?
    Drugs. 2002;62(9):1315-29.
    PMID: 12076181
23. Nzila AM, Nduati E, Mberu EK, Sibley CH, Monks SA, Winstanley PA, Watkins WM.
    Molecular evidence of greater selective pressure for drug resistance exerted by the long-acting antifolate Pyrimethamine/Sulfadoxine compared with the shorter-acting chlorproguanil/dapsone on Kenyan Plasmodium falciparum.
    J Infect Dis. 2000 Jun;181(6):2023-8. Epub 2000 Jun 5.
    PMID: 10837185
24. Pearce RJ, Drakeley C, Chandramohan D, Mosha F, Roper C.
    Molecular Determination of Point Mutation Haplotypes in the Dihydrofolate Reductase and Dihydropteroate Synthase of Plasmodium falciparum in Three Districts of Northern Tanzania.
    Antimicrob Agents Chemother. 2003 Apr;47(4):1347-54.
    PMID: 12654669
25. Plowe CV, Cortese JF, Djimde A, Nwanyanwu OC, Watkins WM, Winstanley PA, Estrada-Franco JG, Mollinedo RE, Avila JC, Cespedes JL, Carter D, Doumbo OK.
    Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance.
    J Infect Dis. 1997 Dec;176(6):1590-6.
    PMID: 9395372
26. Plowe CV, Doumbo OK, Djimde A, Kayentao K, Diourte Y, Doumbo SN, Coulibaly D, Thera M, Wellems TE, Diallo DA.
    Chloroquine treatment of uncomplicated Plasmodium falciparum malaria in Mali: parasitologic resistance versus therapeutic efficacy.
    Am J Trop Med Hyg. 2001 May-Jun;64(5-6):242-6.
    PMID: 11463110
27. Plowe CV, Kublin JG, Doumbo OK.
    P. falciparum dihydrofolate reductase and dihydropteroate synthase mutations:epidemiology and role in clinical resistance to antifolates.
    Drug Resist Updat. 1998;1(6):389-96.
    PMID: 17092820
28. Quaye I, Sibley CH.
    Molecular Data on Plasmodium falciparum chloroquine and antifolate resistance: a public health tool.
    Trends Parasitol. 2002 Apr;18(4):184-186.
29. Rastelli G, Sirawaraporn W, Sompornpisut P, Vilaivan T, Kamchonwongpaisan S, Quarrell R, Lowe G, Thebtaranonth Y, Yuthavong Y.
    Interaction of pyrimethamine, cycloguanil, WR99210 and their analogues with Plasmodium falciparum dihydrofolate reductase: structural basis of antifolate resistance.
    Bioorg Med Chem. 2000 May;8(5):1117-28.
    PMID: 10882022
30. Ringwald P, Basco LK.
    Comparison of in vivo and in vitro tests of resistance in patients treated with chloroquine in Yaounde, Cameroon.
    Bull World Health Organ. 1999;77(1):34-43.
    PMID: 10063659
31. Roper C, Elhassan IM, Hviid L, Giha H, Richardson W, Babiker H, Satti GM, Theander TG, Arnot DE.
    Detection of very low level Plasmodium falciparum infections using the nested polymerase chain reaction and a reassessment of the epidemiology of unstable malaria in Sudan.
    Am J Trop Med Hyg. 1996 Apr;54(4):325-31.
    PMID: 8615441
32. Roper C, Pearce R, Bredenkamp B, Gumede J, Drakeley C, Mosha F, Chandramohan D, Sharp B.
    Antifolate antimalarial resistance in southeast Africa: a population-based analysis.
    Lancet. 2003 Apr 5;361(9364):1174-81.
    PMID: 12686039
33. Shretta R, Omumbo J, Rapuoda B, Snow RW.
    Using evidence to change antimalarial drug policy in Kenya.
    Trop Med Int Health. 2000 Nov;5(11):755-64.
    PMID: 11123822
34. Sibley CH, Hyde JE, Sims PFG, Plowe CV, Kublin JG, Mberu EK, Cowman AF, Winstanley PA, Watkins WM, Nzila AM.
    Pyrimethamine/sulfadoxine resistance in Plasmodium falciparum: What next?
    Trends Parasitol. 2001 Dec;17(12):582-8.
    PMID: 11756042
35. Sidhu ABS, Verdier-Pinard D, Fidock DA.
    Chloroquine Resistance in Plasmodium falciparum Malaria Parasites Conferred by pfcrt Mutations.
    Science. 2002 Oct 4;298(5591):210-3.
    PMID: 12364805
36. Trape JF.
    The public health impact of chloroquine resistance in Africa.
    Am J Trop Med Hyg. 2001 Jan-Feb;64(1-2 Suppl):12-7.
    PMID: 11425173
37. Warhurst DC.
    A molecular marker for chloroquine-resistant falciparum malaria.
    N Engl J Med. 2001 Jan 25;344(4):299-302.
    PMID: 11172160
38. Wellems TE, Plowe CV.
    Chloroquine-resistant malaria.
    J Infect Dis. 2001 Sep 15;184(6):770-6. Epub 2001 Aug 7.
    PMID: 11517439
39. White NJ, Nosten F, Looareesuwan S, Watkins WM, Marsh K, Snow RW, Kokwaro G, Ouma J, Hien TT, Molyneux ME, Taylor TE, Newbold CI, Ruebush TK, Danis M, Greenwood BM, Anderson RM, Olliaro P.
    Averting a malaria disaster.
    Lancet. 1999 Jun 5;353(9168):1965-7.
    PMID: 10371589
40. Winstanley PA.
    Chemotherapy for falciparum malaria: the armoury, the problems and the prospects.
    Parasitol Today. 2000 Apr;16(4):146-53.
    PMID: 10725901
41. Wooden JM, Hartwell LH, Vasquez B, Sibley CH.
    Analysis in yeast of antimalaria drugs that target the dihydrofolate reductase of Plasmodium falciparum.
    Mol Biochem Parasitol. 1997 Mar;85(1):25-40.
    PMID: 9108546
42. Wootton JC, Feng X, Ferdig MT, Cooper RA, Mu J, Baruch DI, Magill AJ, Su XZ.
    Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum.
    Nature. 2002 Jul 18;418(6895):320-3.
    PMID: 12124623
43. Zhang K, Rathod PK.
    Divergent regulation of dihydrofolate reductase between malaria parasite and human host.
    Science. 2002 Apr 19;296(5567):545-7.
    PMID: 11964483